# FDA Inspection 1141435 - Synteract, Inc. - April 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/synteract-inc/cab956b6-e133-4d1e-92fd-a7b5e046b3a6
Source feed: FDA_Inspections

> FDA Inspection 1141435 for Synteract, Inc. on April 29, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141435
- Company Name: Synteract, Inc.
- Inspection Date: 2021-04-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1039237 - 2018-01-12](https://www.keypedia.com/records/fda_inspections/synteract-inc/cd9bde0a-e440-4807-a7d7-28a835b4e92d)
- [FDA Inspection 854134 - 2013-11-04](https://www.keypedia.com/records/fda_inspections/synteract-inc/e4eef964-622a-4c02-9a6b-0c9cacac3b6e)
- [FDA Inspection 661959 - 2010-05-06](https://www.keypedia.com/records/fda_inspections/synteract-inc/c924c22a-3c9c-430b-9ac0-8e125ae754d8)

Company: https://www.keypedia.com/companies/synteract-inc/90e9096e-e453-403c-b889-4b5f7a7a1018

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c